2021
Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States
Simoni MK, Gilstad-Hayden K, Naqvi SH, Pal L, Yonkers KA. Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States. Journal Of Psychosomatic Obstetrics & Gynecology 2021, 43: 214-223. PMID: 34472405, PMCID: PMC10116357, DOI: 10.1080/0167482x.2021.1971193.Peer-Reviewed Original ResearchConceptsAssisted-reproductive technologyEdinburgh Postnatal Depression ScalePlanned pregnanciesPostnatal Depression ScaleGestational time periodsART pregnanciesProspective cohortPregnant womenWeeks postpartumGeneralized Estimating EquationsObstetrical practiceDepression ScaleDepressive symptomsPregnancyBlue studiesSecondary analysisConception groupMental healthAnxiety subscaleAnxiety symptomsWomenGroup changesSymptomsPrevalenceWeeks
2020
Association of Pregnancy Contexts with Depression and Low Social Support in Early Pregnancy
Lundsberg LS, Cutler AS, Stanwood NL, Yonkers KA, Gariepy AM. Association of Pregnancy Contexts with Depression and Low Social Support in Early Pregnancy. Perspectives On Sexual And Reproductive Health 2020, 52: 161-170. PMID: 33047499, DOI: 10.1363/psrh.12155.Peer-Reviewed Original ResearchConceptsLow social supportPregnancy contextPerinatal depressionMultivariable logistic regression analysisSocial supportOdds of depressionPotential risk factorsLogistic regression analysisRegression analysisSocial Support IndexAntenatal depressionWeeks' gestationPrevious diagnosisDepression screenEarly pregnancyEDSS scoresPregnancy intentionRisk factorsPregnancy timingUnplanned pregnancyPregnancy testingPregnancyPregnancy measuresAbortion careDepression
2015
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial
Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2015, 72: 1037-1044. PMID: 26351969, PMCID: PMC4811029, DOI: 10.1001/jamapsychiatry.2015.1472.Peer-Reviewed Original ResearchConceptsPremenstrual dysphoric disorderSymptom-onset dosingSerotonin reuptake inhibitorsDays of mensesSSRI withdrawalSymptom onsetSymptomatic daysMenstrual cycleClinical trialsDysphoric disorderOutcome measuresScale scoreSRI treatmentTreatment of PMDDClinical Global Impression ScaleAbrupt treatment cessationDepressive Symptomatology-ClinicianTotal DRSP scoresSecondary outcome measuresPrimary outcome measureGlobal Impression ScaleIDS-C scoresUniversity Medical CenterSertraline hydrochlorideBeginning of menses
2013
Perinatal smoking and depression in women with concurrent substance use
Forray A, Gotman N, Kershaw T, Yonkers KA. Perinatal smoking and depression in women with concurrent substance use. Addictive Behaviors 2013, 39: 749-756. PMID: 24447885, PMCID: PMC3944019, DOI: 10.1016/j.addbeh.2013.12.008.Peer-Reviewed Original ResearchConceptsPregnant womenConcurrent substance useSubstance usePre-pregnancy smokersSignificant depressive symptomsWeeks of pregnancyMini Neuropsychiatric InterviewDiagnosis of depressionImpact of depressionCourse of smokingNon-depressed groupLinear mixed effects regressionSubstance abuse treatmentPerinatal smokingSmoking postpartumBaseline cohortNeuropsychiatric InterviewMixed effects regressionDepressive symptomsSmokingSmoking behaviorDepressive symptomatologyAbuse treatmentPregnancyPostpartum
2005
Pretreatment pattern of symptom expression in premenstrual dysphoric disorder
Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. Journal Of Affective Disorders 2005, 85: 275-282. PMID: 15780697, DOI: 10.1016/j.jad.2004.10.004.Peer-Reviewed Original ResearchConceptsPremenstrual dysphoric disorderPMDD symptomsMenstrual cycleDysphoric disorderPatient variabilityIntermittent dosing strategyOnset of menstruationDSM-IV criteriaPatients' durationAnxiety/tensionSertraline treatmentDRSP scoresPatient daysDosing strategiesSevere symptomsDay 2SymptomsTreatment studiesPretreatment patternAnger/irritabilityMood swingsMore daysWomenSymptom expressionTreatment implications